Agilent (A) stock price, revenue, and financials

Agilent market cap is $36.1 b, and annual revenue was $6.32 b in FY 2021

$36.1 B

A Mkt cap, 13-May-2022

$1.7 B

Agilent Revenue Q1, 2022
Agilent Gross profit (Q1, 2022)910 M
Agilent Gross profit margin (Q1, 2022), %54.4%
Agilent Net income (Q1, 2022)283 M
Agilent EBIT (Q1, 2022)376 M
Agilent Cash, 31-Jan-20221.1 B
Agilent EV37.7 B
Get notified regarding key financial metrics and revenue changes at AgilentLearn more
Banner background

Agilent Revenue

Agilent revenue was $6.32 b in FY, 2021 which is a 18.4% year over year increase from the previous period.

Embed Graph

Agilent Revenue Breakdown

Embed Graph

Agilent revenue breakdown by business segment: 44.7% from Life Sciences and Applied Markets, 34.8% from Agilent CrossLab and 20.5% from Diagnostics and Genomics

Agilent revenue breakdown by geographic segment: 26.7% from Europe, 35.2% from Asia Pacific and 38.0% from Americas

Agilent Income Statement

Annual

USDFY, 2019FY, 2020FY, 2021

Revenue

5.2b5.3b6.3b

Revenue growth, %

5%3%18%

Cost of goods sold

2.4b2.5b2.9b

Gross profit

2.8b2.8b3.4b

Gross profit Margin, %

54%53%54%

R&D expense

404.0m495.0m441.0m

General and administrative expense

1.5b1.5b1.6b

Operating expense total

1.9b2.0b2.1b

EBIT

941.0m846.0m1.3b

EBIT margin, %

18%16%21%

Interest expense

74.0m78.0m81.0m

Interest income

36.0m8.0m2.0m

Pre tax profit

919.0m842.0m1.4b

Income tax expense

(152.0m)123.0m150.0m

Net Income

1.1b719.0m1.2b

EPS

3.42.33.9

Agilent Balance Sheet

Annual

USDFY, 2019FY, 2020FY, 2021

Cash

1.4b1.4b1.5b

Accounts Receivable

930.0m1.0b1.2b

Inventories

679.0m720.0m830.0m

Current Assets

3.2b3.4b3.8b

PP&E

850.0m845.0m945.0m

Goodwill

3.6b3.6b4.0b

Total Assets

9.5b9.6b10.7b

Accounts Payable

354.0m354.0m446.0m

Short-term debt

616.0m75.0m

Current Liabilities

2.1b1.5b1.7b

Long-term debt

1.8b2.3b2.7b

Total Debt

2.4b2.4b2.7b

Total Liabilities

4.7b4.8b5.3b

Common Stock

3.0m3.0m3.0m

Additional Paid-in Capital

5.3b5.3b5.3b

Retained Earnings

(18.0m)81.0m348.0m

Total Equity

4.7b4.9b5.4b

Debt to Equity Ratio

0.5 x0.5 x0.5 x

Debt to Assets Ratio

0.3 x0.2 x0.3 x

Financial Leverage

2 x2 x2 x

Agilent Cash Flow

Annual

USDFY, 2019FY, 2020FY, 2021

Net Income

1.1b719.0m1.2b

Depreciation and Amortization

238.0m308.0m321.0m

Accounts Receivable

(106.0m)(107.0m)(128.0m)

Inventories

(36.0m)(68.0m)(136.0m)

Accounts Payable

29.0m2.0m64.0m

Cash From Operating Activities

1.0b921.0m1.5b

Purchases of PP&E

(155.0m)(119.0m)(188.0m)

Cash From Investing Activities

(1.6b)(147.0m)(749.0m)

Long-term Borrowings

(702.0m)(1.8b)(2.1b)

Dividends Paid

(206.0m)(222.0m)(236.0m)

Cash From Financing Activities

(299.0m)(717.0m)(696.0m)

Net Change in Cash

(866.0m)59.0m43.0m

Interest Paid

80.0m71.0m76.0m

Income Taxes Paid

159.0m361.0m211.0m

Agilent Ratios

USDQ1, 2019

Revenue/Employee

83.9k

Agilent Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021

Customers (Life Sciences and Applied Markets)

26 k24 k23.7 k25.4 k25.9 k

Customers (Diagnostics and Genomics)

11 k11 k11.5 k10.9 k11.5 k

Customers (Agilent CrossLab)

49 k51 k52.5 k54.6 k58.4 k

Facility Space, sq. ft.

5.9 m6.3 m6.6 m6.6 m6.6 m

Facility Space Owned, sq. ft.

4.3 m4.4 m4.5 m4.6 m4.6 m

Facility Space Leased, sq. ft.

1.6 m1.9 m2.1 m2 m2 m

Agilent Human Capital

FY, 2020FY, 2019FY, 2018
Male, percent20.3%20.7%31%
Female (Management), percent10.1%9.7%14.5%
Male (Management), percent23.2%23.7%35.5%
Female (Board), percent10%9%
Male (Board), percent23.3%24.1%
Female, percent13%12.7%19%